Published online before print October 4, 2007, doi: 10.1161/CIRCRESAHA.106.160515
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 19, 2006
Revised on September 23, 2007
Accepted on September 26, 2007
Targeted Deletion of Thioredoxin-Interacting Protein Regulates Cardiac Dysfunction in Response to Pressure Overload
Jun Yoshioka ;
From the Cardiovascular Division (J.Y., W.A.C., J.G., P.C.S., C.M., R.T.L.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass; the Laboratory of Signal Transduction and Laboratory of Structural Biology (K.I., S.A.G., R.E.L., E.M.), National Institute of Environmental Health Sciences, Research Triangle Park, NC; and the Center for Cancer Research (A.A.B.), Massachusetts Institute of Technology, Cambridge, Mass.
* To whom correspondence should be addressed. E-mail: rlee{at}partners.org.
Biomechanical overload induces cardiac hypertrophy and heart failure, and reactive oxygen species (ROS) play a role in both processes. Thioredoxin-Interacting Protein (Txnip) is encoded by a mechanically-regulated gene that controls cell growth and apoptosis in part through interaction with the endogenous dithiol antioxidant thioredoxin. Here we show that Txnip is a critical regulator of the cardiac response to pressure overload. We generated inducible cardiomyocyte-specific and systemic Txnip-null mice (Txnip-KO) using Flp/frt and Cre/loxP technologies. Compared with littermate controls, Txnip-KO hearts had attenuated cardiac hypertrophy and preserved left ventricular (LV) contractile reserve through 4 weeks of pressure overload; however, the beneficial effects were not sustained and Txnip deletion ultimately led to maladaptive LV remodeling at 8 weeks of pressure overload. Interestingly, these effects of Txnip deletion on cardiac performance were not accompanied by global changes in thioredoxin activity or ROS; instead, Txnip-KO hearts had a robust increase in myocardial glucose uptake. Thus, deletion of Txnip plays an unanticipated role in myocardial energy homeostasis rather than redox regulation. These results support the emerging concept that the function of Txnip is not as a simple thioredoxin inhibitor but as a metabolic control protein.
Key words: cardiac hypertrophy • reactive oxygen species • glucose
Related Article:
- Searching for Causality of Knocking Out Txnip: Is Txnip Missing in Action?
- Roger A. Davis
Circ. Res. 2007 101: 1216-1218.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
 |
|
 |
|
  K. Seki, S. Sanada, A. Y. Kudinova, M. L. Steinhauser, V. Handa, J. Gannon;, and R. T. Lee Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling Circ Heart Fail, November 1, 2009; 2(6): 684 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Tipple, S. E. Welty, L. D. Nelin, J. M. Hansen, and L. K. Rogers Alterations of the Thioredoxin System by Hyperoxia: Implications for Alveolar Development Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 612 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kawashiro, H. Fukata, K. Sato, H. Aburatani, H. Takigami, and C. Mori Polybrominated diphenyl ethers cause oxidative stress in human umbilical vein endothelial cells Human and Experimental Toxicology, November 1, 2009; 28(11): 703 - 713. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Qi, X. Chen, J. Holian, C. Y.R. Tan, D. J. Kelly, and C. A. Pollock Transcription Factors Kruppel-Like Factor 6 and Peroxisome Proliferator-Activated Receptor-{gamma} Mediate High Glucose-Induced Thioredoxin-Interacting Protein Am. J. Pathol., November 1, 2009; 175(5): 1858 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Patwari, W. A. Chutkow, K. Cummings, V. L. R. M. Verstraeten, J. Lammerding, E. R. Schreiter, and R. T. Lee Thioredoxin-independent Regulation of Metabolism by the {alpha}-Arrestin Proteins J. Biol. Chem., September 11, 2009; 284(37): 24996 - 25003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yan, M. E. Young, L. Cui, G. D. Lopaschuk, R. Liao, and R. Tian Increased Glucose Uptake and Oxidation in Mouse Hearts Prevent High Fatty Acid Oxidation but Cause Cardiac Dysfunction in Diet-Induced Obesity Circulation, June 2, 2009; 119(21): 2818 - 2828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-X. Yu, S.-R. Goh, R.-P. Dai, and Y. Luo Adenosine-Containing Molecules Amplify Glucose Signaling and Enhance Txnip Expression Mol. Endocrinol., June 1, 2009; 23(6): 932 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, H. Cha-Molstad, A. Szabo, and A. Shalev Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein Am J Physiol Endocrinol Metab, May 1, 2009; 296(5): E1133 - E1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. West, J. Harral, K. Lane, Y. Deng, B. Ickes, D. Crona, S. Albu, D. Stewart, and K. Fagan Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L744 - L755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Chutkow, P. Patwari, J. Yoshioka, and R. T. Lee Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production J. Biol. Chem., January 25, 2008; 283(4): 2397 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Davis Searching for Causality of Knocking Out Txnip: Is Txnip Missing in Action? Circ. Res., December 7, 2007; 101(12): 1216 - 1218. [Full Text] [PDF]
|
|